Protein C16orf59: A Potential Drug Target and Biomarker (G80178)
Protein C16orf59: A Potential Drug Target and Biomarker
Cancer is one of the leading causes of human mortality, and the development of new treatments is crucial in reducing cancer incidence and mortality. One promising approach to combatting cancer is the identification of potential drug targets and biomarkers. In this article, we focus on an uncharacterized protein called C16orf59 and its potential as a drug target and biomarker in the context of cancer.
C16orf59: A Putative Drug Target
The protein C16orf59 is a gene that encodes a protein with unique features. It has a calculated molecular weight of 13.9 kDa and a predicted localization in the cell's cytoplasm. C16orf59 is expressed in various tissues, including brain, heart, liver, and muscle. It is also highly expressed in human cancer tissues, making it an attractive target for cancer therapies.
Several studies have suggested that C16orf59 may play a role in cancer development. For instance, overexpression of C16orf59 has been shown to promote the growth and metastasis of various cancer types, including breast, lung, and colorectal cancer. Additionally, C16orf59 has been associated with cancer-related inflammation, which is a known predictor of cancer outcomes.
C16orf59 as a Biomarker
The detection of cancer biomarkers is critical for the diagnosis and prognosis of cancer. C16orf59 is a potential biomarker for various types of cancer, including breast, lung, and colorectal cancer. Its expression has been shown to be associated with the severity of cancer-related inflammation, as previously discussed.
In addition to its potential as a biomarker, C16orf59 has also been shown to be a potential drug target. Its unique features and its association with cancer-related inflammation make it an attractive target for small molecules or antibodies that can inhibit its activity.
Conclusion
In conclusion, C16orf59 is an uncharacterized protein that has unique features and has been associated with various aspects of cancer development, including cancer-related inflammation. Its potential as a drug target and biomarker make it an attractive target for new cancer therapies. Further research is needed to fully understand its role in cancer and to develop effective treatments.
Protein Name: Tubulin Epsilon And Delta Complex 2
Functions: Acts as a positive regulator of ciliary hedgehog signaling. Required for centriole stability
More Common Targets
TEDC2-AS1 | TEDDM1 | TEF | TEFM | TEK | TEKT1 | TEKT2 | TEKT3 | TEKT4 | TEKT4P1 | TEKT4P2 | TEKT5 | TEKTIP1 | TELO2 | Telomerase holoenzyme complex | TEN1 | TEN1-CDK3 | Teneurin | TENM1 | TENM2 | TENM2-AS1 | TENM3 | TENM3-AS1 | TENM4 | TENT2 | TENT4A | TENT4B | TENT5A | TENT5B | TENT5C | TENT5C-DT | TENT5D | TEP1 | TEPP | TEPSIN | TERB1 | TERB2 | TERC | TERF1 | TERF1P3 | TERF2 | TERF2IP | TERLR1 | TERT | TES | TESC | TESK1 | TESK2 | TESMIN | TESPA1 | TET1 | TET2 | TET2-AS1 | TET3 | Tetraspanin | TEX10 | TEX101 | TEX11 | TEX12 | TEX13A | TEX13B | TEX13C | TEX14 | TEX15 | TEX19 | TEX2 | TEX21P | TEX22 | TEX26 | TEX261 | TEX264 | TEX28 | TEX29 | TEX30 | TEX33 | TEX35 | TEX36 | TEX36-AS1 | TEX37 | TEX38 | TEX41 | TEX43 | TEX44 | TEX45 | TEX46 | TEX47 | TEX48 | TEX49 | TEX50 | TEX52 | TEX53 | TEX55 | TEX56P | TEX9 | TF | TFAM | TFAMP1 | TFAP2A | TFAP2A-AS1 | TFAP2A-AS2
